Results 61 to 70 of about 6,573 (167)
RAGE Re‐Expressed at Myofibre Level Drives Muscle Wasting in Cancer Conditions
ABSTRACT Background Cancer cachexia (CC) is a highly debilitating syndrome characterized by loss of body and muscle weight affecting most advanced cancer patients. The receptor for advanced glycation end‐products (RAGE) is expressed by several cell types and sustains the inflammatory response in acute and chronic diseases. Total ablation of RAGE (Ager−/
Sara Chiappalupi +10 more
wiley +1 more source
UBC9 directly binds the N-terminal region of PR-Set7.
(A) The indicated recombinant fusion proteins were expressed in E. coli, purified by affinity chromatography and fractionated by SDS-PAGE.
Judd C. Rice (178101) +3 more
core +1 more source
ITSN1 binds the E2-conjugating enzyme UBC9
Aim. Scaffolding protein of the intersectin 1 (ITSN1) associated with malignant cell transformation. A short isoform of ITSN1 (ITSN1-S) can localize to the nucleus and inhibit breast cancer cell proliferation but the exact mechanisms of ITSN1 nuclear ...
K. O. Kozyrieva, T. A. Gryaznova
doaj +1 more source
This review illustrates how scientists engineer exosomes by hijacking the cell's own cargo‐sorting machinery. These strategies efficiently load therapeutic molecules into natural vesicles, creating powerful next‐generation drug delivery systems (Created with BioGDP.com).
Huanrong Zhu +6 more
wiley +1 more source
A mechanistic view of the role of E3 in sumoylation.
Sumoylation, the covalent attachment of SUMO (Small Ubiquitin-Like Modifier) to proteins, differs from other Ubl (Ubiquitin-like) pathways. In sumoylation, E2 ligase Ubc9 can function without E3 enzymes, albeit with lower reaction efficiency.
Melda Tozluoğlu +3 more
doaj +1 more source
Protein sumoylation, especially when catalyzed by the Mms21 SUMO E3 ligase, plays a major role in suppressing duplication-mediated gross chromosomal rearrangements (dGCRs). How Mms21 targets its substrates in the cell is insufficiently understood.
Raymond T Suhandynata +5 more
doaj +1 more source
SUMOylation, a dynamic post‐translational modification, acts as a master regulator at the heart of tumor malignancy. Our work delineates how the SUMOylation cycle—mediated by E1/E2/E3 enzymes and reversed by SENPs—orchestrates multiple hallmarks of cancer. The central pathway converges on three critical pathological axes: 1.
Yimao Wu +6 more
wiley +1 more source
Ischaemic stress has been demonstrated to induce a robust increase in SUMOylation, thereby promoting adaptive mechanisms that regulate protein relocalisation, stabilisation, degradation, and activation. Following hypoxic–ischaemic insult, both SUMO‐1 and SUMO‐2/3 conjugation increase, although the temporal dynamics and subcellular distribution of these
João M. Gissoni +5 more
wiley +1 more source
Introduction Inhibited acute myeloid leukemia (AML) proliferation is accompanied by downregulated peroxisome proliferator-activated receptor a (PPARa), which however can be stabilized via SUMOylation. This study investigated how PPARa SUMOylation impacts
Xiaolu Song +6 more
doaj +1 more source
Background Macroautophagy (hereafter referred to as autophagy) is an evolutionarily conserved intracellular mechanism for lysosomal degradation of damaged cellular components.
Yunong Li +9 more
doaj +1 more source

